GET CERTIFIED IN DRUG SAFETY


RECOGNIZED COURSE QUALITY


DESIGNED FOR EXPERTS BY EXPERTS


HETEROGENEITY OF TREATMENT EFFECT IN CLINICAL TRIALS


OBJECTIVES

Considering the average results of a clinical trial, they often do not apply to all, or even most, individuals in the study. Important differences may exist in relative as well as absolute responses among patients.

This course intends to propose you several approaches for being able to identify clusters of patients with a similar benefit-risk profile, from naive subgroup analyses to more sophisticated procedures.

Absolute answer, Patient, Cluster, Benefit-risk, Profile

 

LEARNING OUTCOMES

At the end of this course, you will be familiar with the concepts related to the heterogeneity of treatment effect and how to interpret the results according to the method used to cope with.

 

120 minutes
Online based learning
English language
Certificate of Achievement
500 €
BOOK NOW

AUTHORS

avatar

Josep Maria Castel

Universitat Autònoma de Barcelona

avatar

Dr. Antònia Agustí

Universitat Autònoma de Barcelona


avatar

Dr. Xavier Vidal

Universitat Autònoma de Barcelona

avatar

Dr. Montse Bosche

Universitat Autònoma de Barcelona




COMPANIES OFFER

Short courses can be included in a training package for your team!


NEED TO TALK TO US?

+33 5 47 30 42 69

Monday-Friday / 9.00am-6.00pm CET

 

Supported By

IMI logo EU logo efpia logo

Created By

Eu2P Partners